StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Sector-similar peers via Finnhub · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | ANAB ANAB | $59.71 | -1.16% | $1.7B | — | 7.5 | +107.7% | — | — |
| 1 | RXRX Recursion Pharmaceuticals | $3.01 | -3.22% | $1.6B | — | 24.1 | +11.1% | 7.2% | 55 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $12.60 |
| +1.86% |
| $1.8B |
| — |
| 26.6 |
| +45.0% |
| — |
| 48 |
| 3 | SNDX SNDX | $19.94 | +0.86% | $1.8B | — | 10.2 | +628.9% | 96.0% | — |
| 4 | VRDN VRDN | $17.24 | -2.54% | $1.7B | — | 24.3 | +23382.8% | 2.4% | — |
| 5 | VCEL VCEL | $34.73 | -1.19% | $1.7B | 80.5 | 5.9 | +22.4% | 74.8% | — |
| 6 | AGIO AGIO | $28.14 | -2.26% | $1.7B | — | 25.3 | +78.3% | 90.0% | — |
| 7 | CAPR CAPR | $28.87 | -2.40% | $1.7B | — | 75.1 | — | — | — |
| 8 | PVLA PVLA | $113.99 | -1.66% | $1.6B | — | 39.9 | -97.2% | — | — |
| 9 | GLUE GLUE | $18.81 | -0.37% | $1.6B | — | 37.0 | -73.1% | — | — |